Dr. Matthas Bartneck is appointed as ERA-Chair holder in Nanomedicine of the ESEI-BioMed project

Dr. Matthias Bartneck is nominated as ERA-Chair on Nanomedicine of the ESEI-BioMed project

Regional Institute of Oncology Iasi is honored to announce that the ERA Chair holder on Nanomedicine is Dr. Matthias Bartneck. Dr. Bartneck is currently Group leader (Immunomodulatory nanomedicine for inflammatory disease and cancer) at the Medical faculty, RWTH Aachen, Germany. He is also Lecturer at the Center for Functional Magnetic Materials, Immanuel Kant Baltic Federal University, Kaliningrad, Russia. He obtained his PhD degree in Natural Sciences in 2010 at RWTH Aachen University, with a topic on the interactions of human primary immune cells with nanoparticles, two-dimensional micropatterns, hydrogels, and three-dimensional nanofibres. Dr. Bartneck is (co-) author of more than 40 papers published in prestigious journals, such as Nature Communications, ACS Appl Mater Interfaces, ACS Nano, Biomaterials, Cellular and Molecular Gastroenterology and Hepatology or Hepatology. He has strong academic and industrial collaborations within Europe and Canada. As ERA-Chair holder he will lead the activities related to set-up an outstanding interdisciplinary team of highly skilled researchers in Nanomedicine with the clear goal to increase the international visibility and translational capability of the TRANSCEND.

  • Share this post!